StockData
Cellectis S.A. logo

Cellectis S.A. (CLLS) stock

CLLSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 20, 2026Score 3/30
$1.06+0.02 (+1.92%)

Close on Nov 17, 2026Market cap $106.36MP/E –Yield –

Cellectis market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cellectis's market cap was $138.96M on Nov 11, 2026, against $508.65M a year earlier. Over the last 5 years it ranged from $53.92M to $508.65M, with a median of $161.15M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$138.96M-71.4%
2025Dec 31, 2025$485.57M+169.5%
2024Dec 31, 2024$180.17M+28.4%
2023Dec 29, 2023$140.29M+46.8%
2022Dec 30, 2022$95.57M-74.1%
2021Dec 31, 2021$369.15M-67.9%
2020Dec 31, 2020$1.15B+58.3%
2019Dec 31, 2019$726.40M+21.3%
2018Dec 31, 2018$598.74M-41.9%
2017Dec 29, 2017$1.03B+72.7%
2016Dec 30, 2016$596.28M-34.7%
2015Dec 31, 2015$913.73M–

More Cellectis figures

See a number that looks wrong?